Bipolar disorder can make your mood, energy, sleep, thinking, and relationships feel unpredictable. If you are experiencing mania, hypomania, depression, or frequent mood shifts, you may wonder: Should treatment start with lithium, an anticonvulsant mood stabilizer, an atypical antipsychotic, or a combination?
There is no single “best” medication for every person. Effective bipolar disorder treatment depends on your current mood episode, medical history, previous medication response, side-effect risks, sleep patterns, co-occurring conditions, and personal goals.
At Light-tunnel Behavioral Health Services Inc. in New Haven, Dr. Omolola Aragbada, PMHNP-BC, and the clinical team provide psychiatric evaluations, medication management, psychotherapy, and individualized treatment planning. Care may be available through an in-person appointment or telehealth appointment, depending on your needs and eligibility.
Bipolar disorder treatment: a side-by-side comparison
| Treatment approach | Often considered for | Potential strengths | Important considerations |
|---|---|---|---|
| Lithium | Mania prevention, long-term maintenance, suicide-risk reduction | Strong evidence for preventing manic relapse and supporting long-term mood stability | Requires blood-level, kidney, thyroid, hydration, and medication-interaction monitoring |
| Anticonvulsant mood stabilizers: valproate or lamotrigine | Valproate: acute mania; lamotrigine: bipolar depression and maintenance | Can target specific mood patterns; lamotrigine may help prevent depressive relapse | Valproate has significant reproductive and metabolic safety concerns; lamotrigine must be increased slowly because of serious rash risk |
| Atypical antipsychotics | Acute mania, bipolar depression, mixed symptoms, or maintenance | Some work relatively quickly and several address both manic and depressive symptoms | Possible sedation, weight change, metabolic effects, movement symptoms, or other medication-specific risks |
| Combination therapy | Severe symptoms, incomplete response, psychosis, rapid cycling, or recurrent episodes | May provide broader symptom coverage than one medication alone | More monitoring, interactions, side effects, and adherence demands |
| Psychotherapy-only or adjunctive therapy | Psychoeducation, relapse prevention, family support, coping, and recovery | Builds skills for recognizing early warning signs, regulating routines, and improving communication | Psychotherapy alone is generally not enough for acute mania or severe bipolar depression |
Think of mood stabilizers as helping regulate the brain’s “electrical system.” Atypical antipsychotics can act more like an emergency brake when mood, thoughts, or behavior accelerate rapidly. Psychotherapy helps you recognize dashboard warning lights (such as reduced sleep, racing thoughts, withdrawal, or impulsive decisions) before a full episode develops.
1. Lithium: a long-term anchor for mood stability
Lithium remains one of the most studied treatments for bipolar disorder. It is commonly considered when the primary goal is to prevent future manic episodes, depressive episodes, or both.
A systematic review of randomized controlled trials found that lithium reduced the risk of mood relapse compared with placebo, with particularly meaningful evidence for preventing mania (Geddes et al., 2004). In comparative research, lithium also performed strongly among medications used for acute mania (Cipriani et al., 2011).
Lithium may be especially appropriate when you have:
- Recurrent manic episodes
- A strong pattern of relapse when medication is stopped
- Bipolar disorder with significant suicide risk
- A need for a long-term maintenance strategy
Lithium requires careful monitoring because it has a relatively narrow therapeutic range. Your psychiatric provider may monitor lithium levels, kidney function, thyroid function, hydration, and possible interactions with other medications. Do not change your dose, stop lithium suddenly, or alter your salt and fluid intake without medical guidance.
Bipolar disorder carries an elevated risk of suicide, particularly during severe depression, mixed states, or abrupt mood changes. In a large randomized-trial meta-analysis involving mood disorders, lithium was associated with fewer completed suicides than placebo (Cipriani et al., 2013). This does not mean lithium eliminates risk, but it is one reason clinicians may discuss it as part of a comprehensive safety and maintenance plan.
2. Valproate and lamotrigine: two different anticonvulsant strategies
Although valproate and lamotrigine are both anticonvulsant medications, they are not interchangeable.
Valproate
Valproate, also called divalproex or valproic acid, is often considered for acute mania, mixed symptoms, or situations in which rapid mood stabilization is needed. It may be particularly useful when irritability, agitation, impulsivity, or decreased sleep are prominent.
However, valproate requires careful review of:
- Pregnancy potential and reproductive safety
- Liver function and platelet counts
- Weight and metabolic health
- Drug interactions
- Possible sedation, tremor, or gastrointestinal effects
Valproate is generally avoided during pregnancy when safer alternatives are available because of important fetal risks. Your clinician should discuss these risks directly and respectfully rather than making assumptions about your personal circumstances.
Lamotrigine
Lamotrigine is more commonly used for bipolar depression and maintenance than for acute mania. It may be a useful option when depressive episodes are the most disabling part of your illness or when preventing depressive relapse is a central goal.
Lamotrigine must be titrated gradually. A new rash, especially with fever, mouth sores, facial swelling, or feeling unwell, requires urgent medical attention. Do not increase the dose faster than prescribed.
3. Atypical antipsychotics: rapid symptom control and broader coverage
Atypical antipsychotics include medications such as quetiapine, olanzapine, aripiprazole, lurasidone, cariprazine, and others. Their roles differ by medication: some are used primarily for mania, some for bipolar depression, and some for maintenance.
A randomized trial comparing olanzapine with divalproex found faster improvement in manic symptoms with olanzapine, although longer-term relapse outcomes were not clearly different between groups (Tohen et al., 2003). Other randomized trials have supported quetiapine as an option for bipolar depression, including the EMBOLDEN studies.
Possible monitoring needs include:
- Weight, blood pressure, glucose, and cholesterol
- Daytime sleepiness or slowed thinking
- Restlessness or akathisia
- Muscle stiffness, tremor, or other movement symptoms
- Medication-specific heart, liver, or hormonal effects
The right choice depends on the episode you are experiencing. A medication that is useful for acute mania may not be the best choice for bipolar depression, and a medication that helps depression may not adequately prevent mania.
4. Combination therapy: when one medication is not enough
Combination therapy may be considered when symptoms are severe, when psychotic features are present, when a medication provides only partial relief, or when relapse continues despite adherence to one medication.
Common combinations may include:
- Lithium plus an atypical antipsychotic
- Valproate plus an atypical antipsychotic
- Lithium plus lamotrigine
- A mood stabilizer plus structured psychotherapy
Combination treatment can be effective, but “more medication” is not automatically “better treatment.” Each additional medication creates another layer of monitoring. Your clinician should regularly review whether every medication still has a clear purpose.
5. Psychotherapy: not a replacement for stabilization, but an important partner
Psychotherapy can help you understand bipolar patterns and build routines that support stability. It may include:
- Cognitive behavioral therapy
- Family-focused therapy
- Psychoeducation
- Interpersonal and social-rhythm therapy
- Sleep and routine planning
- Relapse-prevention work
In the STEP-BD randomized trial, people receiving intensive psychotherapy (including family-focused therapy, CBT, or interpersonal and social-rhythm therapy) recovered from bipolar depression faster than those receiving brief collaborative care (Miklowitz et al., 2007). CBT-based relapse prevention has also been associated with fewer recurrences for some people with bipolar disorder (Lam et al., 2003).
Psychotherapy-only care may be reasonable in limited circumstances, such as education, recovery support, or treatment of a mild co-occurring concern. However, acute mania, severe depression, psychosis, or significant suicide risk generally requires psychiatric assessment and may require medication.
This is also where depression therapy can be helpful. Bipolar depression should not automatically be treated like unipolar major depression. Antidepressant decisions require attention to possible manic or hypomanic switching, mixed symptoms, and the need for mood stabilization first.
How do you choose the right treatment?
During a psychiatric evaluation, your provider may consider:
- Which phase are you in? Mania, hypomania, bipolar depression, mixed symptoms, or maintenance each requires a different strategy.
- What happened with previous medications? Benefit, side effects, adherence, and speed of response all matter.
- What medical factors affect safety? Kidney, thyroid, liver, metabolic, cardiovascular, and reproductive considerations may influence the choice.
- What is your relapse pattern? Some people primarily experience mania; others have repeated depressive episodes.
- What support is available? Sleep, family involvement, therapy, substance-use support, and crisis planning can affect outcomes.
- What fits your life? A treatment plan must be realistic enough for you to follow.
At Light-tunnel Behavioral Health Services Inc., medication management includes reviewing your history, assessing current symptoms, monitoring response, and adjusting treatment carefully. The practice also provides psychiatric evaluations, medication management, and psychotherapy.
Can self-pay clients benefit from care?
Yes. Self-pay clients may choose Light-tunnel Behavioral Health Services Inc. when they want personalized psychiatric or therapy care without relying solely on insurance network availability.
Depending on the service, self-pay benefits may include:
- Clear information about current fees before scheduling
- A comprehensive psychiatric evaluation
- Ongoing medication management
- Therapy and relapse-prevention support
- In-person appointments or eligible telehealth appointments
- Superbills or reimbursement documentation when available
- Evaluation for TMS or Spravato/esketamine when clinically appropriate
TMS and Spravato/esketamine are not automatic treatments for bipolar depression. They require careful diagnostic assessment because antidepressant-focused interventions may carry a risk of mood switching or worsening activation in some individuals. Mood stabilization, screening for mania or mixed symptoms, and close psychiatric monitoring come first.
Learn more through Light-tunnel’s services, accepted insurance information, or contact the practice in New Haven.
References
- Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. American Journal of Psychiatry. 2004;161(2):217–222. PubMed
- Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. The Lancet. 2011;378(9799):1306–1315. PubMed
- Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646. BMJ
- Tohen M, Ketter TA, Zarate CA, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. American Journal of Psychiatry. 2003;160(7):1263–1271. PubMed
- Miklowitz DJ, Otto MW, Frank E, et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from STEP-BD. American Journal of Psychiatry. 2007;164:1340–1347. Article
- Lam DH, Watkins ER, Hayward P, et al. A randomized controlled study of cognitive therapy for relapse prevention in bipolar affective disorder. Archives of General Psychiatry. 2003;60(2):145–152. Article
- Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. The Lancet. 2013;381:1672–1682. DOI
Safety disclaimer
This article is for educational purposes and does not replace a diagnosis, medical evaluation, or individualized treatment plan. Never start, stop, or change psychiatric medication without speaking with a qualified clinician. If you are experiencing suicidal thoughts, feel unable to stay safe, or are having severe mania, psychosis, or dangerous impulsivity, call or text 988 for the Suicide & Crisis Lifeline. Call 911 or go to the nearest emergency department for an immediate emergency.
Continue the Series
How Many TMS Sessions Will I Need? A Realistic Timeline for Depression Treatment